KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
300142 Walvax Biotechnology
- 13.54
- -0.80-5.58%
Market Closed Dec 13 15:00 CST
21.66BMarket Cap175.84P/E (TTM)
14.27High13.47Low1.11MlotVolume14.26Open14.34Pre Close1.52BTurnover7.14%Turnover Ratio51.68P/E (Static)1.60BShares23.9852wk High2.26P/B21.11BFloat Cap9.7852wk Low17.21Limit Up1.56BShs Float96.68Historical High11.47Limit Down5.58%Amplitude3.57Historical Low0.01Dividend TTM13.70Avg Price555.19KlotAsk0.07%Div YieldTTM100Lot Size443.56KlotBid
Walvax Biotechnology News
Watson Biotech: Announcement on receiving the “Drug Clinical Trial Approval Notice” for adsorbed tetanus vaccine
Watson Biotech: Prompt Announcement for the Disclosure of the 2024 Third Quarter Report
Watson Biotech: Internal Reporting System for Important Information (October 2024)
Watson Biotech: Announcement on the calculation of credit impairment preparations and asset impairment preparations for the third quarter of 2024
Watson Biotech: Investor Relations Management System (October 2024)
Watson Biotech: Announcement of Resolutions of the 24th Meeting of the Fifth Board of Directors
Watson Biotech: Information Disclosure Management System (October 2024)
Watson Biotech: Q3 2024 Report
Watson Biotech: Announcement of Resolutions of the 18th Meeting of the Fifth Board of Supervisors
Watson Biotech: Announcement on the subsidiary receiving the Oman Product Registration Certificate for the 13-valent pneumococcal polysaccharide conjugate vaccine
Watson Biotech: Announcement on the subsidiary receiving a license to market the bivalent HPV vaccine in Indonesia
Watson Biotech: Notice on Completing the Registration of Business Changes
Watson Biotech: 300142 Watson Biotech Investor Relations Management Information 20240905
Watson Biotech: 300142 Watson Biotech Investor Relations Management Information 20240903
Watson Biotech: 300142 Watson Biotech Investor Relations Management Information 20240830
Watson Biotech: Special Report on the Deposit and Actual Use of Funds Raised for the First Half of 2024
Watson Biotech: Announcement on the Company\'s Receipt of an Invention Patent Certificate
Watson Biotech: Announcement on subsidiaries applying for comprehensive credit lines from banks
Watson Bio: 2024 Semi-Annual Report Summary
Watson Biotech: Announcement of Board Resolutions
